95 related articles for article (PubMed ID: 26923410)
1. Novel inflammatory markers associated with cognitive performance: Singapore Longitudinal Ageing Studies.
Gao Q; Camous X; Lu YX; Lim ML; Larbi A; Ng TP
Neurobiol Aging; 2016 Mar; 39():140-6. PubMed ID: 26923410
[TBL] [Abstract][Full Text] [Related]
2. Association of inflammatory biomarkers with depressive symptoms and cognitive decline in a community-dwelling healthy older sample: a 3-year follow-up study.
Matsushima J; Kawashima T; Nabeta H; Imamura Y; Watanabe I; Mizoguchi Y; Kojima N; Yamada S; Monji A
J Affect Disord; 2015 Mar; 173():9-14. PubMed ID: 25462389
[TBL] [Abstract][Full Text] [Related]
3. High-dose glucocorticoids increase serum levels of soluble IL-6 receptor alpha and its ratio to soluble gp130: an additional mechanism for early increased bone resorption.
Dovio A; Perazzolo L; Saba L; Termine A; Capobianco M; Bertolotto A; Angeli A
Eur J Endocrinol; 2006 May; 154(5):745-51. PubMed ID: 16645023
[TBL] [Abstract][Full Text] [Related]
4. Components of the interleukin-6 transsignalling system are associated with the metabolic syndrome, endothelial dysfunction and arterial stiffness.
Weiss TW; Arnesen H; Seljeflot I
Metabolism; 2013 Jul; 62(7):1008-13. PubMed ID: 23428306
[TBL] [Abstract][Full Text] [Related]
5. Glycoprotein 130 polymorphism predicts soluble glycoprotein 130 levels.
Wonnerth A; Katsaros KM; Krychtiuk KA; Speidl WS; Kaun C; Thaler K; Huber K; Wojta J; Maurer G; Seljeflot I; Arnesen H; Weiss TW
Metabolism; 2014 May; 63(5):647-53. PubMed ID: 24629561
[TBL] [Abstract][Full Text] [Related]
6. Plasma soluble gp130 levels are increased in older subjects with metabolic syndrome. The role of insulin resistance.
Zuliani G; Galvani M; Maggio M; Volpato S; Bandinelli S; Corsi AM; Lauretani F; Cherubini A; Guralnik JM; Fellin R; Ferrucci L
Atherosclerosis; 2010 Nov; 213(1):319-24. PubMed ID: 20869059
[TBL] [Abstract][Full Text] [Related]
7. Pre-B-cell colony-enhancing factor is markedly elevated in childhood hemophagocytic lymphohistiocytosis.
Gao ZY; Li XY; Bhandari V; Li LD; Lan D
Genet Mol Res; 2015 May; 14(2):5287-95. PubMed ID: 26125724
[TBL] [Abstract][Full Text] [Related]
8. [Determination of serum soluble interleukin-6 receptor and soluble gp130 levels in patient with pregnancy induced hypertension and its significance].
Li Y; Wang Y; Qi L
Zhonghua Fu Chan Ke Za Zhi; 2001 Jan; 36(1):18-9. PubMed ID: 11778537
[TBL] [Abstract][Full Text] [Related]
9. Clinical relevance of elevated levels of serum soluble interleukin-2 receptor alpha (sIL-2Rα) in patients with non-Hodgkin's lymphoma.
Jo SA; Hwang SH; Chang CL; Kim SY; Shin HJ; Chung JS; Sol MY; Lee EY
Korean J Lab Med; 2010 Dec; 30(6):600-5. PubMed ID: 21157146
[TBL] [Abstract][Full Text] [Related]
10. Comprehensive serum cytokine analysis identifies IL-1RA and soluble IL-2Rα as predictors of event-free survival in T-cell lymphoma.
Gupta M; Stenson M; O'Byrne M; Maurer MJ; Habermann T; Cerhan JR; Weiner GW; Witzig TE
Ann Oncol; 2016 Jan; 27(1):165-72. PubMed ID: 26487586
[TBL] [Abstract][Full Text] [Related]
11. The diagnostic significance of soluble CD163 and soluble interleukin-2 receptor alpha-chain in macrophage activation syndrome and untreated new-onset systemic juvenile idiopathic arthritis.
Bleesing J; Prada A; Siegel DM; Villanueva J; Olson J; Ilowite NT; Brunner HI; Griffin T; Graham TB; Sherry DD; Passo MH; Ramanan AV; Filipovich A; Grom AA
Arthritis Rheum; 2007 Mar; 56(3):965-71. PubMed ID: 17328073
[TBL] [Abstract][Full Text] [Related]
12. Circulating levels of interleukin 6 soluble receptor and its natural antagonist, sgp130, and the risk of myocardial infarction.
Moreno Velásquez I; Golabkesh Z; Källberg H; Leander K; de Faire U; Gigante B
Atherosclerosis; 2015 Jun; 240(2):477-81. PubMed ID: 25910182
[TBL] [Abstract][Full Text] [Related]
13. Serum level of soluble interleukin-2 receptor alpha as a predictor of treatment response in brucellosis.
Kahbazi M; Rezapour H; Jafari F; Arjomandzadegan M; Sofian M; Zarinfar N; Sarmadiayan H; Najmi AR
J Ayub Med Coll Abbottabad; 2012; 24(2):44-6. PubMed ID: 24397050
[TBL] [Abstract][Full Text] [Related]
14. Serum interleukin-6 receptor in polymyalgia rheumatica: a potential marker of relapse/recurrence risk.
Pulsatelli L; Boiardi L; Pignotti E; Dolzani P; Silvestri T; Macchioni P; Cantini F; Salvarani C; Facchini A; Meliconi R
Arthritis Rheum; 2008 Aug; 59(8):1147-54. PubMed ID: 18668607
[TBL] [Abstract][Full Text] [Related]
15. Circulating levels of sgp130 and sex hormones in male patients with coronary atherosclerotic disease.
Cui Y; Dai W; Li Y
Atherosclerosis; 2017 Nov; 266():151-157. PubMed ID: 29028483
[TBL] [Abstract][Full Text] [Related]
16. Association of soluble interleukin-2 receptor α and tumour necrosis factor receptor 1 with heart failure: The Multi-Ethnic Study of Atherosclerosis.
Bakhshi H; Varadarajan V; Ambale-Venkatesh B; Meyghani Z; Ostovaneh MR; Durda P; Wu CO; Tracy RP; Cushman M; Bluemke DA; Lima JAC
ESC Heart Fail; 2020 Apr; 7(2):639-644. PubMed ID: 32155316
[TBL] [Abstract][Full Text] [Related]
17. Profiles of cognitive subtest impairment in the Montreal Cognitive Assessment (MoCA) in a research cohort with normal Mini-Mental State Examination (MMSE) scores.
Markwick A; Zamboni G; de Jager CA
J Clin Exp Neuropsychol; 2012; 34(7):750-7. PubMed ID: 22468719
[TBL] [Abstract][Full Text] [Related]
18. Soluble gp130 is up-regulated in the implantation window and shows altered secretion in patients with primary unexplained infertility.
Sherwin JR; Smith SK; Wilson A; Sharkey AM
J Clin Endocrinol Metab; 2002 Aug; 87(8):3953-60. PubMed ID: 12161539
[TBL] [Abstract][Full Text] [Related]
19. Soluble interleukin-2 receptor and metalloproteinase-9 expression in head and neck cancer: prognostic value and analysis of their relationships.
El Houda Agueznay N; Badoual C; Hans S; Gey A; Vingert B; Peyrard S; Quintin-Colonna F; Ravel P; Bruneval P; Roncelin S; Lelongt B; Bertoglio J; Fridman WH; Brasnu D; Tartour E
Clin Exp Immunol; 2007 Oct; 150(1):114-23. PubMed ID: 17680822
[TBL] [Abstract][Full Text] [Related]
20. Circulating interleukin 6 and soluble forms of its receptors in relation to resting energy expenditure in women with anorexia nervosa.
Karczewska-Kupczewska M; Adamska A; Nikołajuk A; Otziomek E; Górska M; Kowalska I; Strączkowski M
Clin Endocrinol (Oxf); 2013 Dec; 79(6):812-6. PubMed ID: 23199226
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
